Funded Tech Companies

Attovia Therapeutics

Researching who backed Attovia Therapeutics? Nextech, Illumina Ventures and venBio Partners joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Attovia is focused on creating a pipeline of biotherapeutics in immune-mediated disease and oncology. The company leverages AttobodyTM, Alamar Biosciences' novel biparatopic nanobody platform, to generate small format binders with low picomolar affinity, enhanced specificity, accelerated internalization and fast tissue penetration. Attovia's lead program is an Attobody to treat immune disease. The company is currently progressing multiple programs and plans to initiate additional discovery projects.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/9/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Tao Fu

        

Chief Technical Officer

Hangjun Zhan

        

Co-Founder

Yuling Luo

        

Company Investors

• Nextech
• Illumina Ventures
• venBio Partners
• Frazier Life Sciences
• EcoR1 Capital Management
• Logos Capital
• Marshall Wace
• Cormorant Asset Management
• Goldman Sachs (Colin Walsh)
• Redmile Group

Browse more funded tech companies:

AttoTude | Attralus

Share this article

About Our Venture Capital Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary